Wireless Monitoring in Chronic Heart Failure

Use of a wireless implantable device to monitor patients with NYHA class III heart failure reduces hospitalization and improves heart failure management.

Part of a series of podcasts created by the editors of The Lancet in order to “discuss journal highlights, including interviews with authors of key articles to provide context and insight to advancements in medicine and health worldwide,” this installment features William Abraham, MD, discussing the article “Wireless Pulmonary Artery Haemodynamic Monitoring in Chronic Heart Failure: A Randomised Controlled Trial.” The article presented results from the CHAMPION study, which was designed to “evaluate the safety and efficacy of the HF Pressure Measurement System in reducing heart failure (HF) related hospitalizations in a subset of subjects suffering from HF.”

Click here to access and download this third-party podcast resource.